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Abstract
Background
Gestational hypothyroidism (G-HypoT) is one of the most common thyroid diseases in preg-
nant women. Human milk, which closely links the mother with infant, is an important factor
to the infant health. Here, we analyzed the colostrum whey proteome of women with or with-
out G-HypoT.
Methods and results
Using high–mass accuracy and high-resolution liquid chromatography-tandem mass spec-
trometry (LC-MS/MS), 1055 proteins were identified. Tandem Mass Tags (TMT) analysis
identified differentially expressed proteins between G-HypoT and non-G-HypoT mothers.
Of 44 proteins identified, 15 proteins were significantly increased in G-HypoT colostrum
whey, while 29 were significantly decreased. Analysis revealed that enzymes involved in
carbohydrate metabolism, and that reflect the metabolic activities in breastfeeding women,
including fructose-1, 6-bisphosphatase 1, phosphoglycerate mutase 1 were down-regu-
lated. Cell structural proteins, biomarkers of mammary integrity development, including
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and actin were lower in G-HypoT
colostrum whey. However, immune protein fragments like Ig gamma-3 chain C region
increased in G-HypoT colostrum whey.
Conclusion
These results implied that G-HypoT may changed human colostrum whey protein in compo-
sition level, decreasing levels of metabolic proteins and cell-structure proteins, while
increasing levels of immune-related proteins, which may compromise or reflect mothers’
and infants’ health.
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Introduction
Hypothyroidism (HypoT), characterized by an increased level of thyrotropin (TSH) and a
decreased level of free thyroxine (T4), affects 3–10% of women; its onset frequently occurs dur-
ing child-bearing years, triggered by the physiological changes in the thyroid during pregnancy
[1–3]. Overt hypothyroidism is defined as TSH concentrations above the reference range and
free T4 levels below the reference range, while subclinical hypothyroidism is defined as TSH
levels above the reference range when levels of free T4 are within the population reference
range [4, 5]. In China, G-HypoT has emerged with an increasing prevalence in pregnant
women. Since the clinical symptoms of HypoT, such as fatigue, constipation, cold intolerance,
muscle cramps, edema, dry skin, hair loss, and a prolonged relaxation phase of deep tendon
reflexes, are easily confused with common signs of pregnancy, therefore they are often ignored
by pregnant women [6]. However, the resultant deleterious effects on the mothers themselves
and especially their offspring cannot be ignored. Some studies show that gestational HypoT is
associated with severe preeclampsia, gestational diabetes, abruptio placentae, a higher inci-
dence of preterm birth, increased fetal mortality, slow weight gain, and impaired cognitive
development in offspring [3, 7–9]. Human milk provides an important link between mothers
and their infants, and the effects of HypoT on lactation are gaining increasing attention.
Previous studies reported that HypoT directly or indirectly regulates transcription in mam-
mary cells by regulating levels of circulating hormones such as corticosterone, prolactin, and
progesterone which can impact the quality and quantity of milk synthesis [10]. This may be
attributed to the fact that prolactin promotes mRNA synthesis of milk proteins such as β-
casein and α-lactalbumin, and adequate concentrations of thyroid hormones are essential for
milk production in response to prolactin [11]. Another report demonstrated that propyl-
2-thiouracil-induced HypoT histological changes consistent with early involution of mam-
mary tissue in lactating rats [12]. Motil et al. reported that the plasma thyroxine level of moth-
ers is not only positively correlated with the quantity of milk production, but also affects
synthesis of milk protein [13–15]. However, a comprehensive analysis of the breast milk pro-
tein profiles of G-HypoT mothers has yet to be reported.
Proteomic technologies could be applied to improving our knowledge of the proteins
present in breastmilk. Several studies have characterized the proteome of human breastmilk in
different conditions, such as different gestational duration [16], lactation time [17, 18], and
health state during lactation [19, 20]. Grapov et al. (2015) leveraged the high mass accuracy,
high resolution, and rapid scanning ability of the Q Exactive Orbitrap mass spectrometer
to explore the effects of gestational diabetes mellitus (GDM) on lactation and breast milk
components. Among the total 601 proteins identified, 260 were quantified using label-free
spectral counting. Hettinga et al. (2015) also used a label-free method to identify differences in
milk proteins between allergic and non-allergic mothers, and found that 19 of the total 364
proteins identified differed significantly in concentration between the breast milk of allergic
and non-allergic mothers [20]. These approaches have greatly advanced our knowledge of
milk proteins, but they have not been applied determining the effects of G-HypoT on the pro-
teome of human colostrum. Colostrum is the first best natural food for the newborn, it has
more bioactive compounds than mature milk, which lay the foundation of infants immune
protection.
In the current study, we isolated whey from colostrum collected from women with or
without G-HypoT, and analyzed the proteome using high-resolution, high–mass accuracy liq-
uid chromatography tandem mass spectrometry (LC−MS/MS). To our knowledge, this is the
first study to investigate how the proteome of human colostrum is altered by gestational
hypothyroidism.
Whey proteome and gestational hypothyroidism
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Materials and methods
Experimental reagents
Rabbit antibody against complement 4b (C4b), complement factor H (H), human immuno-
globulin G (IgG), and mouse antibody against Complement 3 (C3) were obtained from
Abcam (Cambridge, UK). Rabbit antibody against α-tubulin, GAPDH, and β-actin were pur-
chased from Cell Signaling Technology (Beverly, MA, USA). β-actin antibodies were obtained
from Beyotime (Nantong, China).
Subject enrollment
Colostrum samples were obtained from women who delivered term infants and were diag-
nosed with (n = 8) or without G-HypoT (n = 8) at the General Army Hospital of Beijing (Bei-
jing, China). Participants were screened for G-HypoT based on routine obstetrical
examination results. Subjects with serum thyrotropin higher than 2.5 mIU/L and serum total
thyroxine less than 40 ng/mL in first trimester of pregnancy were diagnosed with G-HypoT, as
suggested by the Chinese Society of Endocrinology and the Chinese Society of Perinatal Medi-
cine in 2012. Mothers with G-HypoT received thyroxine replacement therapy during preg-
nancy. Mothers with maternal illnesses, such as cold, mastitis, or diabetes, were excluded.
Written informed consent was obtained from each participant, and this study was approved
by the Institutional Review Board (IRB) at the General Army Hospital (No.100). Diet, anthro-
pometric and health history, and status upon collection were obtained from self-reported
questionnaires.
Milk sample collection and processing
Colostrum samples were collected from each breast by hand expression or manual breast
pump into 50 mL polypropylene containers within 48 h of lactation initiation [18, 21]. All sam-
ples were immediately transported to the lab on ice and stored at −80˚C. Samples from each
subject were analyzed independently without pooling. As fat and casein disturbs the proteo-
mics analysis, milk samples were thawed and then centrifuged at 10,000 × g at 4˚C for 10 min
to remove the cream layer. Aliquots of skim milk were centrifuged at 100,000 × g at 4˚C for 60
min to pellet the casein micelles [22]. The transparent milk serum fraction was collected and
the final concentration of whey protein was measured by the bicinchoninic acid (BCA)
method.
LC-MS based proteomics with TMT labelling
In-solution digestion was performed according to the procedure described by Chen et al. [23].
Equal amount (100 μg) of whey protein samples was diluted with 8 M urea in PBS and treated
with dithiothreitol (DTT, final concentration of 10 mM) for 1 h, and alkylated with iodoaceta-
mide (IAA, 25 mM) for 30 min in the dark. After alkylation, samples were diluted and sub-
jected to in vitro digestion using trypsin (in PBS; 1:100 protease-to-protein ratio)at 37˚C
overnight. The samples were then desalted using Oasis HLB columns (Waters, MA) and
labeled with TMT reagents before LC MS/MS analysis. The S1 File (Supplemental Experimen-
tal Procedures) contain details about the MS parameters used for these analyses.
Data processing strategy and statistical analysis
For each identified protein, the relative abundance in a specifically labelled sample was calcu-
lated as the ratio of its abundance in this sample to that in the pooled sample (1055 proteins).
Only proteins detected in at least five samples in both groups, G-HypoT and non-G-HypoT,
Whey proteome and gestational hypothyroidism
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were selected for statistical analysis (472 proteins). Protein relative abundance data and acces-
sion numbers were imported into R [24] integrated with R studio [25] for data analysis. Data
from three runs were combined following a previously described procedure [26]. Each effect
feature was fitted to two linear mixed-effect models with and without the disease condition as
the fixed-effect factor, with TMT plex number as a random-effect factor, using the lmer func-
tion in the package ‘lme4’ [27]. P-values were generated by comparing these two models with
the ANOVA function. GO annotation of these proteins was carried out using the Database for
Annotation, Visualization and Integrated Discovery (DAVID) software using the Homo sapi-
ens genome as a reference [28, 29]. All differentially expressed proteins between colostral whey
from women with versus without G-HypoT were evaluated for GO term enrichment for bio-
logical processes, molecular functions, cellular components, and KEGG pathway. The total
identified proteins were used as a background set. Significantly overrepresented terms were
identified using the hypergeometric test (p-value� 0.05) [30]. Protein interaction networks
were analyzed using Search Tool for the Retrieval of Interacting Genes/Proteins (STRING; ver-
sion 10.0) [31].
Western blotting
For western blotting, equal amounts of whey protein were separated by SDS-PAGE, followed
by transfer of proteins to a polyvinylidene difluoride membrane (Millipore, Temecula, USA).
The membrane was incubated with primary antibodies, followed by incubation with horserad-
ish peroxidase-conjugated secondary antibody. The washed blot was detected using chemilu-
minescence (Amersham ECL™, GE Healthcare, Buenos Aires, Argentina) and quantified by
densitometry using QuantityOne (Bio-Rad). Since expression of proteins commonly used for
quantitation was affected by HypoT induction, we used a densitometric analysis of the total
protein intensity by Ponceau staining as a loading control [32].
Results
Number of characterized proteins in human colostrum
Table 1 shows that non-G-HypoT and G-HypoT mothers had very similar demographic char-
acteristics in maternal age, pregnancy weight increase, maternal BMI. All mothers had no mas-
titis infection. After removal of casein and fat, the aqueous whey fraction of colostrum was
obtained. Overall, 1055 proteins were identified in all mothers’ colostrum samples, in triplicate
experiments (for details, see S1 Table), and 472 final proteins were used in subsequent statisti-
cal and multivariate data analyses.
Differentially expressed colostral whey proteins between non-G-HypoT
and G-HypoT mothers
Fig 1 shows the mean log2 ratio of abundance values of the milk from G-HypoT mothers over
non-G-HypoT mothers. This volcano figure shows the proteins up-regulated in G-HypoT
mothers on the right, and the down-regulated proteins on the left. Statistical analysis indicated
that a total of 44 proteins were differentially expressed (for details, see Table 2). Among these,
29 proteins were down-regulated and 15 proteins were up-regulated.
Biological functions and subcellular localization of identified proteins
The 44 proteins were categorized by both their subcellular location and their function based
on annotations in the UniProt Database. Fig 2A shows that the majority of the differentially
expressed proteins were cytoplasmic (48%), and only 16% were secreted proteins that function
Whey proteome and gestational hypothyroidism
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in the extracellular space. Proteins originating from organelles, the nucleus, and the membrane
accounted for approximately 12% of the total; the subcellular location of approximately 25% of
proteins was unclear.
Table 1. Demographics of subjects with and without gestational hypothyroidism.
Characteristics non-G-HypoT (n = 8) G-HypoT (n = 8)
Mean ± SD Max. Min. Mean ± SD Max. Min.
maternal age (y) 31.1 ± 3.9 37.0 26.0 31.5 ± 4.6 37.0 23.0
maternal height (cm) 163.2 ± 5.2 170.0 158.0 165.0 ± 4.9 170.0 160.0
pregnancy weight increase(kg) 17.8 ± 7.3 30.0 5.0 13.3 ± 5.5 22.0 4.5
maternal prepregnancy BMI (kg/m 2) 21.5 ± 2.4 24.0 17.3 22.9 ± 3.6 28.2 17.8
maternal pregnancy BMI (kg/m 2) 28.1 ± 2.8 30.5 22.3 27.7 ± 4.1 32.0 23.1
gestational age of infant (week) 39.6 ± 1.4 41.1 36.9 38.9 ± 0.7 38.3 40.1
Infant birth length (cm) 51.1±1.1 53.0 50.0 52.40±1.6 55.0 50.0
infant birth weight (kg) 3.4 ± 0.4 4.0 2.9 3.5 ± 0.4 2.9 4.1
Infant jaundice duration (d) 30±17.3 30 7 50±14.1 60 30
Frequencies
primiparous/multiparous 5/3 7/1
c-section/vaginal 6/2 8/0
female/male 5/3 3/5
https://doi.org/10.1371/journal.pone.0205987.t001
Fig 1. Differences in the proteome of milk from mothers with or without gestational hypothyroidism.
https://doi.org/10.1371/journal.pone.0205987.g001
Whey proteome and gestational hypothyroidism
PLOS ONE | https://doi.org/10.1371/journal.pone.0205987 October 17, 2018 5 / 18
Table 2. Differentially expressed proteins in human colostral whey.
Accession Protein name Gene name Biological function Subcellular function fold change
Down-regulated in G-HypoT
P07900 Heat shock protein HSP 90-alpha HSP90AA Signaling transduction Cytoplasm -1.31
Q99832-3 Isoform 3 of T-complex protein 1 subunit eta CCT7 Protein metabolism Cytoplasm -1.4
P60709 Actin, cytoplasmic 1 ACTB Cell motility Cytoplasm -1.33
P63267 Actin, gamma-enteric smooth muscle ACTG2 Cell motility Cytoplasm -1.44
Q15293-2 Isoform 2 of Reticulocalbin-1 RCN1 Lipid metabolism ER -1.24
P13639 Elongation factor 2 EEF2 Protein metabolism Cytoplasm -1.3
P32119 Peroxiredoxin-2 PRDX2 Redox response Cytoplasm -1.25
P60953 Cell division control protein 42 homolog CDC42 Cell motility Cytoplasm -1.24
P06733 Alpha-enolase ENO1 Carbohydrate Metabolism Cytoplasm -1.33
P18669 Phosphoglycerate mutase 1 PGAM1 Carbohydrate Metabolism Cytoplasm -1.28
P07737 Profilin-1 OS = Homo sapiens PFN1 Cell motility Cytoplasm -1.44
P60174-1 Isoform 2 of Triosephosphate isomerase TPI1 Carbohydrate Metabolism Cytoplasm -1.25
Q8NC51-4 Isoform 4 of Plasminogen activator inhibitor 1 RNA-binding protein SERBP1 Nucleic acid metabolism Cytoplasm -1.23
H3BRU6 Poly(rC)-binding protein 2 (Fragment) PCBP2 Nucleic acid metabolism Unclear -1.29
P09467 Fructose-1,6-bisphosphatase 1 FBP1 Carbohydrate metabolism Cytoplasm -1.31
P68032 Actin, alpha cardiac muscle 1 ACTC1 Cell motility Cytoplasm -1.35
Q16851 UTP—glucose-1-phosphate uridylyltransferase UGP2 Nucleic acid metabolism Cytoplasm -1.36
P23528 Cofilin-1 CFL1 Cell motility Cytoplasm -1.34
Q96KP4 Cytosolic non-specific dipeptidase CNDP2 Protein metabolism Cytoplasm -1.23
A0A075B6I9 Protein IGLV7-46 (Fragment) IGLV7-46 Unclear Unclear -1.26
E7EQG2 Eukaryotic initiation factor 4A-II EIF4A2 Nucleic acid metabolism Unclear -1.27
J3KPD9 Nucleoside diphosphate kinase B NME2 Signaling transduction Unclear -1.25
P04406 Glyceraldehyde-3-phosphate dehydrogenase GAPDH Carbohydrate Metabolism Cytoplasm -1.34
P62937 Peptidyl-prolyl cis-trans isomerase A PPIA Protein metabolism Cytoplasm -1.26
J3KNQ2 Fibronectin type III domain-containing protein 1 (Fragment) FNDC1 Unclear Unclear -1.72
P07195 L-lactate dehydrogenase B chain LDHB Carbohydrate Metabolism Cytoplasm -1.35
P30086 Phosphatidylethanolamine-binding protein 1 PEBP1 Signaling transduction Cytoplasm -1.28
G3V1A4 Cofilin 1 (Non-muscle), isoform CRA_a CFL1 Cell motility Cytoplasm -1.31
P29401 Transketolase TKT Carbohydrate metabolism Nucleus -1.37
Up-regulated in G-HypoT
B1AMI1 ATP-binding cassette sub-family A member 1 ABCA1 Unclear Unclear 1.35
Q16651 Prostasin PRSS8 Unclear Secreted 1.27
A0A087WVJ0 Mucin-1 (Fragment) MUC1 Protein metabolism Membrane 1.32
E9PNW4 CD59 glycoprotein CD59 Immunity Unclear 1.25
H3BTQ8 Kunitz-type protease inhibitor 1 (Fragment) SPINT1 Unclear Unclear 1.22
P07996 Thrombospondin-1 THBS1 Immunity ER 1.35
K7EK07 Histone H3 (Fragment) H3F3B Unclear Nucleus 1.41
P04003 C4b-binding protein alpha chain C4BPA Immunity Secreted 1.35
A0A075B6K5 HCG2043239 (Fragment) IGLV3-9 Unclear Unclear 1.74
Q5VZR0 Golgi-associated plant pathogenesis-related protein 1 GLIPR2 Unclear Secreted 1.4
F5H2L1 G-protein-coupled receptor 126 (Fragment) GPR126 Unclear Unclear 1.23
P01608 Ig kappa chain V-I region Roy Immunity Secreted 1.64
P25311 Zinc-alpha-2-glycoprotein AZGP1 Immunity Secreted 1.31
A0A087WXL8 Ig gamma-3 chain C region IGHG3 Immunity Unclear 1.29
Q13410 Butyrophilin subfamily 1 member A1 BTN1A1 Lipid metabolism Secreted 1.24
https://doi.org/10.1371/journal.pone.0205987.t002
Whey proteome and gestational hypothyroidism
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As shown in Fig 2B, metabolism-related proteins appeared to be the main biological func-
tion group (36%), especially carbohydrate metabolism. Cytoskeletal proteins accounted for
16%, and 7 of the 44 differentially expressed proteins were involved in immune response. No
clear GO annotation was available for 23% of proteins, which makes it difficult to clarify their
relationship with G-HypoT mothers and/or infants.
Fig 2. Different protein classifications and western blot validation. (A) Functional categorization of 44 proteins identified in the
significance analyses. (B) Subcellular location of all 44 proteins identified in the significance analyses. The number of proteins in each
category is indicated in parentheses. Enrichment analysis of differentially expressed proteins (C) Gene ontology (D) KEGG pathway.
https://doi.org/10.1371/journal.pone.0205987.g002
Whey proteome and gestational hypothyroidism
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Gene ontology and KEGG pathway enrichment analysis
Fig 2C shows that 44 altered proteins in G-HypoT were enriched (p< 0.05) in gene ontology
(GO) for many terms for biological processes, molecular functions, and cellular components.
Among biological processes, the most significantly (p< 0.001) enriched terms were GO:
0016051 (carbohydrate biosynthetic process), GO: 0006936 (muscle contraction), GO:
0003012 (muscle system process), and GO: 0046364 (monosaccharide biosynthetic process).
These can be summarized as muscle systems and carbohydrate metabolism. Among cellular
components, the most significantly (p< 0.001) enriched term was GO: 0005829 (cytosol).
Among molecular functions, nine terms were significantly (p< 0.001) enriched, all associated
with compound binding. Fig 2D shows the results of KEGG pathway analysis, with darker col-
ors indicating deeper KEGG enrichment; however, no KEGG pathways were significantly
enriched.
Hierarchical cluster analysis
In Fig 3, each column contains differentially expressed proteins clustered by individual mother
and each row contains individual differentially expressed proteins clustered between the two
groups. Red text indicates higher expression and green text indicates lower expression. Except
in two mothers, which may be attributed to individual differences, milk from G-HypoT and
non-G-HypoT mothers showed two distinct cluster patterns. As shown in Fig 3, non-
G-HypoT mothers clustered mainly to the left, whereas G-HypoT mothers clustered to the
right. Most of the up-regulated proteins were higher in G-HypoT colostrum (red), such as
immune-related protein P01608 (Ig kappa chain V-I region Roy) and A0A087WXL8 (Ig
gamma-3 chain C region) (Table 2). Some proteins were also down-regulated in G-HypoT
mothers, shown in green, such as the cytoskeletal proteins actin, tubulin, and GAPDH. Thus,
the proteomic differences between the two groups were mainly due to their concentration
instead of the presence or absence of specific proteins. To visualize whether these differences
in protein intensity were due to a few outliers or consistent differences between the groups, the
data for individual mothers for the six proteins that showed the largest differences, P63267
(actin, gamma-enteric smooth muscle), P07737 (profilin-1 OS = Homo sapiens), J3KNQ2
(fibronectin type III domain-containing protein 1 (Fragment)), K7EK07 (histone H3 (Frag-
ment)), A0A075B6K5 (HCG2043239 (Fragment)), and P01608 (Ig kappa chain V-I region
Roy), were plotted. Fig 4 shows that for these six proteins, the significant differences were due
to systematic differences between groups, not outliers.
Western blot validation
Some cell structural proteins, such as actin and GAPDH, showed lower expression in
G-HypoT milk. These proteins are known to be housekeeping proteins, and their expression is
typically stable. We validated this result using western blotting. Fig 5A shows that actin, tubu-
lin, and GAPDH were indeed down-regulated in G-HypoT mothers’ milk.
Immune proteins in human breast milk are known to play a critical role in protecting
infants from disease [22]. Our results showed that some immune globulins were highly
expressed in colostral whey from G-HypoT women compared to non-G-HypoT women, such
as P01608 (Ig kappa chain V-I region Roy) and P25311 (Ig gamma-3 chain C region), which
are domains of immunoglobulins. Another important immune system is the complement
system, which is activated by two major pathways, the classical pathway and the alternative
pathway. We wondered whether complement proteins were also affected by G-HypoT. We
measured levels of the classical pathway and the alternative pathway characteristic components
C3 and CFH (complement factor H), as well as C4b, a key protein involved in the first step of
Whey proteome and gestational hypothyroidism
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the complement cascade, by western blotting. However, they showed no significant differences
(Fig 5B).
Fig 3. Hierarchical clustering of differentially expressed colostral whey proteins between mothers with or without
gestational hypothyroidism. Bar color represents a logarithmic scale from −0.4 to 0.4. Red indicates higher expression and
green indicates lower expression.
https://doi.org/10.1371/journal.pone.0205987.g003
Whey proteome and gestational hypothyroidism
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Protein-protein interaction network
Analysis of the protein-protein interaction network was conducted using STRING (Fig 6).
Thirty-seven of the 44 differentially expressed proteins were directly correlated, 11 of which
were up-regulated and 26 of which were down-regulated. Down-regulated proteins GAPDH,
Actin, alpha cardiac muscle 1 (ACTC1), Actin, cytoplasmic 1 (ACTB)(cytoskeletal-related)
and Alpha-enolase (ENO1), Isoform 2 of Triosephosphate isomerase (TPI1), Phosphoglycerate
mutase 1 (PGAM1), L-lactate dehydrogenase B chain (LDHB), Transketolase (TKT) (carbohy-
drate metabolism related) were closely associated with each other. They may have interactions
in expression and play a critical role in the network.
Discussion
Overview of the colostrum whey proteome
We annotated a total of 1055 proteins from the whey fraction of human breastmilk using a
TMT-labeling proteomic approach. We identified a total of 44 differentially expressed proteins
(for details, see Table 2); of these 29 were down-regulated and 15 were up-regulated in
G-HypoT. These proteins were associated with three major functional classes: carbohydrate
metabolism (down-regulated), cytoskeleton (down-regulated), and immunity (up-regulated)
(Fig 6).
Energy metabolism is modulated in the milk of G-HypoT mothers
Differentially expressed proteins involved in carbohydrate metabolism, protein metabolism,
and lipid metabolism were uniformly lower in G-HypoT mothers. The proteins alpha-enolase
(P06733), phosphoglycerate mutase 1 (P18669), isoform 2 of triosephosphate isomerase
(P60174-1), fructose-1, 6-bisphosphatase 1 (P09467), glyceraldehyde-3-phosphate dehydroge-
nase (P04406), L-lactate dehydrogenase B chain (P07195), and transketolase (P29401) are all
enzymes that participate in carbohydrate metabolism, performing functions such as gluconeo-
genesis and glycolysis. It is known that the processes and pathways mediating the metabolism
of carbohydrates, lipids, and proteins are all affected by thyroid hormones (THs) in almost all
Fig 4. Abundance for six proteins in individual colostrum samples from mothers with or without gestational
hypothyroidism.
https://doi.org/10.1371/journal.pone.0205987.g004
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tissues [33]. Thus, changes in thyrotropin and/or thyroxine (T4) levels will affect the metabolic
processes of G-HypoT mothers. As thyroid hormones are galactopoietic and help to establish
the mammary gland metabolic priority during lactation, pregnancy needs mobilize this hor-
mone to make preparation for laction. So it may need more thyroid hormones during preg-
nancy, this may aggravates a state of clinical or subclinical hypothyroidism, and adequate
function of the mammary glands may be compromised [11]. One of the most marked conse-
quences of maternal hypothyroidism on the offspring is stunted growth and delayed maturation
of the newborn that leads to mental retardation and subnormal height [10]. Newborn infants
rely on their mothers’ milk to obtain nutrition and energy to meet the needs of fast growth.
Fig 6 shows that several enzymes related to carbohydrate metabolism were down-regulated,
including GAPDH, ENO1, TPI1, PGAM1, LDHB, and TKT. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) is a key enzyme in glycolysis that catalyzes the first step of the path-
way by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl
Fig 5. Western blot validation. (A) cell structural proteins between two groups from three individual donors. (B)
complement proteins between two groups from three individual donors. C3, complement C3; C4b, complement C4b;
CFH, complement factor H.
https://doi.org/10.1371/journal.pone.0205987.g005
Whey proteome and gestational hypothyroidism
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phosphate. ENO1 (alpha-enolase) is involved in the subpathway that synthesizes pyruvate
from D-glyceraldehyde 3-phosphate. TPI1 (triosephosphate isomerase) is involved in the glu-
coneogenesis pathway, catalyzing conversion of D-glyceraldehyde 3-phosphate to glycerone
phosphate. PGAM1 (phosphoglycerate mutase 1) is the primer in the interconversion of 3-
and 2-phosphoglycerate with 2, 3-bisphosphoglycerate. LDHB (L-lactate dehydrogenase B
chain) is involved in the subpathway that synthesizes (S)-lactate from pyruvate. TKT (transke-
tolase) catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose
acceptor, via a covalent intermediate, with the cofactor thiamine pyrophosphate. Carbohy-
drates are a vital source of energy, and a lower level of carbohydrate metabolism proteins in
the colostrum reflects a weakened metabolic status in mothers. This may aggravate G-HypoT
mothers’ discomfort, increasing anemia, fatigue, anorexia, or a combination of these condi-
tions. While we had no date to show the hormonal condition influence on the laction time and
milk volume, further study need take this into account. ENO1, TPI1, PGAM1, LDHB, and
Fig 6. Protein−protein interaction network for differentially colostral whey proteins between mothers with or without gestational
hypothyroidism. Proteins up-regulated in the G-HypoT group were labeled with up red arrows, and down-regulated proteins were
labeled with down blue arrows.
https://doi.org/10.1371/journal.pone.0205987.g006
Whey proteome and gestational hypothyroidism
PLOS ONE | https://doi.org/10.1371/journal.pone.0205987 October 17, 2018 12 / 18
TKT are carbohydrate metabolism enzymes, most of which are involved in glycolysis of the
energy production pathway. The physiological function of TPI1 is to maintain the homeostasis
between dihydroxyacetone phosphate and glyceraldehyde-3-phos-phate produced by aldolase
in glycolysis, which is interconnected to the pentose phosphate pathway and to lipid metabo-
lism via triosephosphates [34]. Infant dietary fat intake is very high due to their high energy
requirement and beneficial effects of fat on growth and development of the brain and vision.
Approximately 50% of the total energy intake is acquired from milk lipids during the first
month after birth, and body fat accounts for 35% of an infant’s weight gain during the first 6
months [35, 36, 37]. Milk contains enzymes that help to balance three major nutrients trans-
formation, especially lipid synthesis and breakdown [37]. So down-regulated energy metabo-
lism enzymes may influence infants’ energy requirement. Another critical aspect, infants’
gastro-intestinal tracts are immature, changes in carbohydrate metabolism enzymes, which are
supposed to be relatively stable during gastric digestion, may affect the gastroenteric function
of baby [38]. So a reduction in enzymes may cause unbalanced digestion and absorption,
which would place a burden on the infant and influence their growth. We found infant dura-
tion of jaundice was longer in G-HypoT (50±14.1) than no-G-HypoT(30±17.3). As G-HypoT
mothers underwent thyroxine therapy, it would improve the G-HypoT thyroxine levels. We
thought G-HypoT would result in a comprehensive disorder of the whole physical state. The
medication therapy improves the thyroxine levels in hypothyroidism state, but may not be able
to let patients recovery completely from the disorder state. So whether the therapy controlled
levels of thyroid hormones optimally or not, the G-HypoT mother whole physiological state
may not healthy as the non-G-HypoT to some degree. But therapy may decrease the differ-
ences in colostrum proteome between G-HypoT and no-G-HypoT, thus decrease the influence
on the baby and mother, as Table 1 showed no difference in the infant birth weight (3.4 ± 0.4
kg in non-G-HypoT VS 3.5 ± 0.4 kg in G-HypoT) and length (51.1±1.1 cm in non-G-HypoT
VS 52.40±1.6 cm in G-HypoT). A large and long-period prospective cohort studies may show
obvious phenotypes in infants and/or mothers. Of course, we need further deliberate study to
clarify if and/or how therapy affect the proteome changes.
We also detected lower levels of proteins involved in protein metabolism in G-HypoT
mothers’ milk, including some enzymes related to protein synthesis. In accordance with thy-
roid hormones can increase protein synthesis in organ culture [39], hypothyroidism may
reduce protein production in mammary glands, as shown in our results.
Cytoskeletal proteins were down regulated in colostrum of mothers with
G-HypoT
Cytoskeletal proteins are often used as loading controls for western blot analysis, due to their
usual, stable expression Nevertheless in this study, cell structural proteins were all down-regu-
lated in G-HypoT mothers’ milk (Fig 6). Western blot analysis of actin, tubulin, and GAPDH
verified the proteomic results (Fig 5A). β-Actin, α-tubulin, and lamin B expression, indicative
of the activation of apoptotic pathways and tissue remodeling, are strongly increased in
G-HypoT lactating rats mammary glands[12]. Sokolowski et al. proposed that caspase activa-
tion leads to the breakdown of cytoskeletal actin and tubulin dimers [40]. This may brought
about an increase in the dynamics of these proteins in mammary glands, along with the initia-
tion of tissue remodeling, ultimately leading to pre-lactational mammary tissue architecture
involution. Cell self-repair regulation may locked these proteins in mammary gland for
rebuilding cell cytoskeleton and premature involution of mammary glands impairs milk pro-
tein production including cytoskeletal proteins. This induces a decrease in the relative abun-
dance of milk cytoskeletal proteins together, as shown in our results.
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G-HypoT changed immune protein levels in colostrum
Human milk is a primary source of immune protection for newborns. Our results showed that
expression of six out of seven immune-related proteins was higher in colostral whey from
G-HypoT women compared to non-G-HypoT women. P01608 (Ig kappa chain V-I region
Roy) and P25311 (Ig gamma-3 chain C region) are domains of immunoglobulins. While the
increasing Ig gamma is the light chain of IgG, G-HypoT, as a pathological state, may stimulated
the mother IgG production to compensate weaker immunity. In production of colostrum,
immunoglobulins pass through mammary epithelial cells from the interstitial spaces between
them. The tight junctions of mammary epithelial cells develop leaks during colostrum produc-
tion. But during mature lactation, immunoglobulins can only enter the milk via transcytosis
across mammary epithelial cells. This means that the degree of differentiation and integrity of
mammary epithelial cells play a key role in entry of immunoglobulins into milk. Campo Verde
Arbocco et al. reported that lactating G-HypoT rats have premature mammary involution, with
more debris in the lumen of the alveoli and significantly decreased percentages of total and
active alveoli in mammary gland morphology [12]. In Fig 5A, cytoskeletal proteins were
decreased in G-HypoT colostrum, reflecting defects in the integrity of mammary glands, which
may have permitted increased leakage of immunoglobulins into milk. As discussed above, some
immune-related proteins were significantly higher in the milk of G-HypoT mothers (Table 2).
The complement system, another important immune component in human milk, was also
different between G-HypoT and non-G-HypoT. As the humoral backbone of the innate
immune defense system, the complement system has three converging enzymatic cascades: the
classical pathway, the alternative pathway and the lectin pathway [41]. The complement system
pathway is a complex cascade reaction involving different components. The final goal is to
construct molecular tags (C4b and C3b) that interact with complement receptors, facilitating
engulfment of target cells. The complement system is important to control of bacterial and
viral infection. Newborns do not possess mature immune capability, and they rely on human
milk, especially colostrum, to obtain protection. CD59 was higher in colostrum of G-HypoT
mothers. CD59 is a regulator, which acts as an inhibitor of complement-mediated cytolysis,
and increased levels of CD59 may reduce infants’ ability to resist pathogens. The main compo-
nents C3, C4b, and the regulator CFH were detected in both groups, with no significant differ-
ence between the two groups (Fig 5B).
Other altered proteins
Peroxiredoxin-2, which is involved in oxidative stress regulation, protecting cells, enzymes,
and other proteins from oxidative damage, was also down-regulated in G-HypoT mothers [42,
43]. Isoform 2 of reticulocalbin-1 (Rcn1), a calcium-binding protein that is involved in the bio-
logical process of camera-type eye development and in utero embryonic development, was
also down-regulated. It belongs to the family of GREC proteins that are characterized as cal-
cium-binding protein in the endoplasmic reticulum (ER) with EF hands (multiple helix-loop-
helix motifs with high affinity for Ca2+ binding) [44]. Rcn1 is widely expressed in various fetal
and adult organs, and is present in ependymal cells, neuroblasts, and a minority of glial cells in
the fetal brain [45]. Although the functional properties of the members of the CREC family are
largely unknown, the members of this family are highly conserved may also in the milk, imply-
ing important roles in the maintenance of normal cell behavior [44]. Decreased expression
may have a negative effect on infants and/or mothers. These proteins are meaningful targets
for further investigation, although it is unclear whether they are functionally active in the
infant gut. A major milk mucin, MUC1, which is a signaling molecule, was up-regulated in
milk of mothers with G-HypoT. As MUC1 is a tumor antigen and oncoprotein that is
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overexpressed in most tumors, including breast, pancreatic, ovarian, and colon cancers, our
result suggests that hypothyroidism may induce abnormal cell metabolism and proliferation of
mammary gland cells [46]. This protein should also be considered for its effects on the health
of pregnant women. The MUC1 inhibits binding of S-fimbriated Escherichia coli to buccal
epithelial cells, it provides protection for infant [47]. The up-regulated MUC1 may be a nega-
tive-feedback of weak immunity in both mothers and infants.
Conclusions
In this observational study, we identified a total of 1055 proteins in human colostrum and
found that 44 proteins were differentially expressed in the colostral whey proteome between
mothers with and without G-HypoT. G-HypoT possible influenced the human whey proteome
of colostrum, decreasing metabolic and cell-structure proteins and increasing immunity-related
proteins, which may affect the transportation of nutrition and bioactive components for infants.
We found that theduration of jaundice was longer in infants of G-HypoT (50±14.1) mothers
than no-G-HypoT(30±17.3) mothers. But there was no difference in infant birth length and
weight between the two groups. May be a more large sample will show difference, or therapy
relief hypothroidism influence on mothers and thus the milk. So influence of alteration caused
by G-HypoT may need a period to make difference on clinical characteristics of infant health.
Since our sample size was small, large prospective cohort studies should be performed to verify
our findings. The impact of maternal gestational hypothyroidism on infant growth index and
nutrient status should also be taken into account, along with changes in milk components dur-
ing the course of lactation. The present study provides insight into proteomic differences in the
colostral whey of G-HypoT women in comparison to non-G-HypoT women.
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